VCU Health’s position as a global leader in fighting opioid use disorder includes recent efforts to reverse the toxicity of a potent synthetic opioid, and the university’s strength in addiction research continues to drive innovation in treatment programs.
VCU researchers have engineered a virus to target and kill cancer cells.
VCU School of Dentistry is jumpstarting a 50-year lag in targeted therapies for head and neck cancer.
VCU Health’s strength in orthopaedics has inspired three gifts that help align the department for continued excellence.
Ryan Mire, M.D., leads third annual DEI lecture and inaugural Wellness Council Lectureship on the historical perspective of systemic racism in medical education.
To share some of the latest progress in VCU Health's global leadership of sickle cell disease research and care development, the MCV Foundation hosted its second Finding a Cure for Sickle Cell Anemia Together virtual event Dec. 4.
The program will increase diversity in clinical trials.
Trustee Susan G. Kornstein, M.D., shares how she became involved with the foundation, the inspiration behind her work and her plans to continue advancing women's health research.
After discovering new insights on how certain tumors respond better to treatment, two VCU researchers are breathing new life into a platinum-based drug to treat cancers resistant to available therapies.
A consortium of Central Virginia institutions rich in history and expertise has come together to establish the region as a national leader in physical rehabilitation care and research.
One patient who was paralyzed in 2013 after a combat-related seizure led to a fall is now participating in a clinical trial to improve his mobility and health.
Cecil Hamlett shares his experience amyloidosis and how the correct diagnosis and heart transplant at VCU Health saved his life.
Your generosity inspires innovation, encourages excellence and transforms dreams into discoveries. Discover your great place in the VCU Health community.
Giving
